| Company Name: | Hanger Orthopedic Group, Inc. | | Ticker Symbol: | HGR | | | WWW Address: | www.hanger.com | | CEO: | Thomas F. Kirk, Ph.D. | | No. of Employees: | 3,211 | | Common Issue Type: | CS | | Business Description: | The Company is an owner and operator of orthotic & prosthetic patient-care centers.
|
| | | Industry Information: | HEALTH SERVICES - Specialized Health Services [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 13.62 |  0.2 | 13.57 | 13.6 | 13.37 | 13.60 | 13.20 | 46996 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 431.8 | 31.7 | 0.37 | 0.78 | 0.00 | 13.3 | 0.0 | 16.37 - 11.10 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 13.42 | $ | | PE Ratio - LTM | 13.3 | |
| Market Capitalisation | 425.1 | mil |
| Latest Shares Outstanding | 31.7 | mil |
| Earnings pS (EPS) | 0.78 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 218,975 | $ |
| Effective Tax Rate | 39.8 | % |
| Float | 30.5 | mil |
| Float as % of Shares Outstanding | 96.7 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 25.00 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 39.1 | % |
| EBITDA Margin | 14.2 | % |
| Pre-Tax Profit Margin | 7.2 | % |
| Assets Turnover | 0.9 | % |
| Return on Assets (ROA) | 3.8 | % |
| Return on Equity (ROE) | 10.6 | % |
| Return on Capital Invested (ROCI) | 4.6 | % |
| Current Ratio | 3.9 | |
| Leverage Ratio (Assets/Equity) | 2.8 | |
| Interest Cover | 2.7 | |
| Total Debt/Equity (Gearing Ratio) | 1.36 | |
| LT Debt/Total Capital | 57.0 | % |
| Working Capital pS | 6.91 | $ |
| Cash pS | 2.47 | $ |
| Book-Value pS | 9.51 | $ |
| Tangible Book-Value pS | -5.68 | $ |
| Cash Flow pS | 1.64 | $ |
| Free Cash Flow pS | 1.16 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.41 | |
| Price/Tangible Book Ratio | -2.36 | |
| Price/Cash Flow | 8.2 | |
| Price/Free Cash Flow | 11.6 | |
| P/E as % of Industry Group | 45.0 | % |
| P/E as % of Sector Segment | 57.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 1.1 | 100 | 1,303 | 2,986 |
| 4 Weeks | 14.04 | 13.02 | 13.84 | -3.0 | 91 | 1,174 | 19,959 |
| 13 Weeks | 14.96 | 13.02 | 14.06 | -4.6 | 89 | 1,714 | 104,528 |
| 26 Weeks | 15.42 | 12.18 | 14.70 | -8.7 | 76 | 1,946 | 243,196 |
| 52 Weeks | 16.37 | 11.10 | 16.05 | -16.4 | 68 | 2,181 | 543,056 |
| YTD | 16.37 | 11.10 | - | -7.5 | 76 | 2,168 | 492,030 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 13.36 | 13.41 | 13.91 | 13.81 | 13.60 | 0.37 | 0.16 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 5.36 | 92.2 | 6.98 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 0.42 | NA | 46.78 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 7.2 | 7.6 | 10.3 |
| Earnings % | 27.9 | 31.4 | 38.8 |
| EPS % | 46.2 | 30.4 | 21.9 |
| EPS $ | 0.24 | 0.07 | 0.14 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 24.61 |
| Current Ratio | 3.7 |
| Quick Ratio (Acid Test) | 2.2 |
| Liquidity Ratio (Cash) | 0.86 |
| Receivables Turnover | 7.1 |
| Average Collection Period | 51 |
| Working Capital/Equity | 75.0 |
| Working Capital pS | 6.19 |
| Cash-Flow pS | 1.24 |
| Free Cash-Flow pS | 0.70 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 2.01 |
| Financial Leverage Ratio (Assets/Equity) | 3.0 |
| Debt Ratio | 67.2 |
| Total Debt/Equity (Gearing Ratio) | 1.58 |
| LT Debt/Equity | 1.57 |
| LT Debt/Capital Invested | 69.0 |
| LT Debt/Total Liabilities | 76.5 |
| Interest Cover | 2.4 |
| Interest/Capital Invested | 4.40 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 3.71 |
| Tobin's Q Ratio | 0.52 |
| Current P/E Ratio - LTM | 13.30 |
| Enterprise Value (EV)/EBITDA | 9.39 |
| Enterprise Value (EV)/Free Cash Flow | 47.20 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | -2.36 |
| Price/Book Ratio - LTM | 1.41 |
| Price/Cash Flow Ratio | 8.2 |
| Price/Free Cash Flow Ratio - LTM | 11.6 |
| Price/Sales Ratio | 0.57 |
| P/E Ratio (1 month ago) - LTM | 14.2 |
| P/E Ratio (26 weeks ago) - LTM | 19.9 |
| P/E Ratio (52 weeks ago) - LTM | 23.3 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 45.0 |
| P/E as % of Sector Segment | 57.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 13.0 |
| PER SHARE FIGURES |
| LT Debt pS | 12.93 |
| Current Liabilities pS | 2.28 |
| Tangible Book Value pS - LTM | -5.68 |
| Book Value pS - LTM | 9.51 |
| Capital Invested pS | 21.63 |
| Cash pS - LTM | 2.47 |
| Cash Flow pS - LTM | 1.64 |
| Free Cash Flow pS - LTM | 1.16 |
| Earnings pS (EPS) | 0.78 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 3.21 |
| Free Cash Flow Margin 5YEAR AVG | 2.28 |
| Net Profit Margin | 3.8 |
| Net Profit Margin - 5YEAR AVRG. | 1.4 |
| Equity Productivity | 2.63 |
| Return on Equity (ROE) | 10.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 4.6 |
| Capital Invested Productivity | 1.03 |
| Return on Capital Invested (ROCI) | 3.9 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 1.5 |
| Assets Productivity | 0.90 |
| Return on Assets (ROA) | 3.3 |
| Return on Assets (ROA) - 5YEAR AVRG. | 1.2 |
| Gross Profit Margin | 39.1 |
| Gross Profit Margin - 5YEAR AVRG. | 51.3 |
| EBITDA Margin - LTM | 14.2 |
| EBIT Margin - LTM | 11.4 |
| Pre-Tax Profit Margin | 6.3 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 2.8 |
| Effective Tax Rate | 39.8 |
| Effective Tax Rate - 5YEAR AVRG. | 27.2 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 140 |
| Revenue per Employee | 218,975 |
| Net Income per Employee | 8,329 |
| Average Collection Period | 51 |
| Receivables Turnover | 7.1 |
| Day's Inventory Turnover Ratio | 89 |
| Inventory Turnover | 4.1 |
| Inventory/Sales | 12.2 |
| Accounts Payble/Sales | 2.67 |
| Assets/Revenue | 1.11 |
| Net Working Capital Turnover | 3.51 |
| Fixed Assets Turnover | 1.30 |
| Total Assets Turnover | 0.9 |
| Revenue per $ Cash | 12.04 |
| Revenue per $ Plant | 13.86 |
| Revenue per $ Common Equity | 2.63 |
| Revenue per $ Capital Invested | 1.03 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 37.7 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 37.9 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |